0001209191-22-002483.txt : 20220107 0001209191-22-002483.hdr.sgml : 20220107 20220107173054 ACCESSION NUMBER: 0001209191-22-002483 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220105 FILED AS OF DATE: 20220107 DATE AS OF CHANGE: 20220107 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Kirk Christopher J. CENTRAL INDEX KEY: 0001744253 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38542 FILM NUMBER: 22519059 MAIL ADDRESS: STREET 1: C/O KEZAR LIFE SCIENCES, INC. STREET 2: 4000 SHORELINE COURT, SUITE 300 CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Kezar Life Sciences, Inc. CENTRAL INDEX KEY: 0001645666 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 473366145 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 4000 SHORELINE COURT, SUITE 300 CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 BUSINESS PHONE: 650-822-5600 MAIL ADDRESS: STREET 1: 4000 SHORELINE COURT, SUITE 300 CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2022-01-05 0 0001645666 Kezar Life Sciences, Inc. KZR 0001744253 Kirk Christopher J. C/O KEZAR LIFE SCIENCES, INC. 4000 SHORELINE COURT, SUITE 300 SOUTH SAN FRANCISCO CA 94080 1 1 0 0 President and CSO Employee Stock Option (right to buy) 14.55 2022-01-05 4 A 0 170000 0.00 A 2032-01-04 Common Stock 170000 170000 D One forty-eighth (1/48th) of the shares shall vest on a monthly basis commencing on January 5, 2022, subject to the Reporting Person continuing to provide service through each such date. /s/ Marc Belsky, Attorney-in-Fact 2022-01-07